Blog

41 Articles

pancreatic cancer patient Leanne Pierce and family
Survivor Stories
November 29, 2021 • 4 Min

A Second Opinion Leads to Hope for the Future

Leanne Pierce decided to go to a major cancer center for a second opinion after her pancreatic cancer diagnosis.

DNA image
Research
November 22, 2021 • 2 Min

Using Molecular Tumor Profiling to Determine the Best Pancreatic Cancer Treatment

A clinical trial looks at whether molecular subtyping of tumors is effective in determining the best pancreatic cancer treatment.

Doctor talking to a patient in a hospital bed
Disease Management
March 5, 2021 • 4 Min

The Pancreatic Standard of Care is No Longer So Standard

Do you want to understand more about how your doctor chooses your treatments? Learn about the standard of care for pancreatic cancer.

Tumor Board Tuesday logo and Twitter icon
Research
February 1, 2021 • 4 Min

Tweeting About Tumors and How Best to Provide Care

Dr. Michael Pishvaian launches #TumorBoardTuesday, a continuing medical education Twitter chat, to discuss patient treatments for GI cancers.

Lola Rahib, Ph.D.
Disease Management
January 29, 2021 • 8 Min

Cancer Commons: Democratizing Cancer Care

Do you need a different treatment for your pancreatic cancer? Lola Rahib explains how Cancer Commons Virtual Tumor Board works for patients.

Noelle LoConte, MD
Research
January 13, 2021 • 5 Min

Finding More Targets for Pancreatic Cancer Treatment

Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.

xWords to know
Treatments
December 21, 2020 • 5 Min

This Versus That: Words to Know

Confused about some of the similar-sounding terms you are hearing during pancreatic cancer treatment? Our list of words to know can help.

Pancreatic cancer patient Chris Joseph
Survivor Stories
November 16, 2020 • 4 Min

Practicing Gratitude Every Day

The best thing Chris Joseph ever did was change oncologists. His new doctor did genetic testing on Chris’s tumor, for better treatment.

pancreatic cancer patient Gina Harrison and her grandsons
Survivor Stories
August 18, 2020 • 4 Min

The Value of Molecular Profiling and Genetic Testing

Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.

PanCAN CSO Lynn Matrisian
Research
April 3, 2020 • 5 Min

Tumor Biology Matters

Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.

Dr. E. Gabriela Chiorean
Treatments
December 27, 2019 • 5 Min

Chemotherapy: A Key Player in the Battle Against Pancreatic Cancer

Dr. Gabriela Chiorean walks us through the different types of chemotherapy treatments for pancreatic cancer and how they work. Join Let’s Win PC in our fight.

pancreatic cancer patient Colin Gabriel
Survivor Stories
October 14, 2019 • 5 Min

Learning to Guide My Pancreatic Cancer Treatment

The more Colin Gabriel learned about pancreatic cancer, the more he realized he needed to guide his treatment, rather than go where his HMO recommended.

pancreatic cancer patient Rick Baker and his wife Shelley
Survivor Stories
May 10, 2019 • 5 Min

Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments

With stage IV pancreatic cancer, Rick Baker got molecular profiling which helped direct his different treatments, including clinical trials.

pancreatic cancer long-term survivor Roy Vinke in the snow
Survivor Stories
February 12, 2019 • 4 Min

Genomic Profiling of my Pancreatic Cancer Gave me a New Lease on Life

When standard treatment did not work for Roy Vinke, he had genomic profiling done. A mutation was found, changing his treatment plan.

Doron Broman, center left, surrounded by others includ Dr. Kimmie Ng on the far right.
Survivor Stories
October 23, 2018 • 3 Min

Molecular Sequencing Leads to Customized Treatment

When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.